PharmaLundensis AB (PHAL)

Currency in SEK
0.330
-0.044(-11.76%)
Closed·
PHAL Scorecard
Full Analysis
Stock generally trades with low price volatility
PHAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3250.361
52 wk Range
0.2261.507
Key Statistics
Bid/Ask
0.325 / 0.372
Prev. Close
0.374
Open
0.325
Day's Range
0.325-0.361
52 wk Range
0.226-1.507
Volume
21.79K
Average Volume (3m)
38.65K
1-Year Change
-47.99%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

PharmaLundensis AB Company Profile

PharmaLundensis AB operates as a pharmaceutical company. The company develops Iodocarb for treating chronic obstructive pulmonary disease; and treatments for chronic bronchitis and influenza-induced lung failure. It develops EcoFilter, a system that eliminates the release of pharmaceutical drugs and multi-resistant bacteria in hospital wastewater. PharmaLundensis AB was founded in 2006 and is based in Lund, Sweden.

Compare PHAL to Peers and Sector

Metrics to compare
PHAL
Peers
Sector
Relationship
P/E Ratio
−4.3x−6.6x−0.5x
PEG Ratio
−0.15−0.190.00
Price/Book
3.4x9.0x2.6x
Price / LTM Sales
-68.1x3.3x
Upside (Analyst Target)
-56.9%43.5%
Fair Value Upside
Unlock10.8%6.8%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PHAL Income Statement

FAQ

What Stock Exchange Does PharmaLundensis Trade On?

PharmaLundensis is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for PharmaLundensis?

The stock symbol for PharmaLundensis is "PHAL."

What Is the PharmaLundensis Market Cap?

As of today, PharmaLundensis market cap is 19.29M.

What Is PharmaLundensis's Earnings Per Share (TTM)?

The PharmaLundensis EPS (TTM) is -0.08.

From a Technical Analysis Perspective, Is PHAL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has PharmaLundensis Stock Split?

PharmaLundensis has split 0 times.

How Many Employees Does PharmaLundensis Have?

PharmaLundensis has 1 employees.

What is the current trading status of PharmaLundensis (PHAL)?

As of 09 Aug 2025, PharmaLundensis (PHAL) is trading at a price of 0.33, with a previous close of 0.37. The stock has fluctuated within a day range of 0.33 to 0.36, while its 52-week range spans from 0.23 to 1.51.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.